Follow

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Follow
LinkedIN Twitter Instagram Youtube
Contact
LinkedIN Twitter Instagram Youtube

SFDA approves Qfitlia for bleeding prevention in hemophilia patients

by
December 18, 2025
SFDA approves Qfitlia for bleeding prevention in hemophilia patients SFDA approves Qfitlia for bleeding prevention in hemophilia patients

Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has approved Qfitlia (Fitusiran) for the prevention or reduction of bleeding episodes in adults and adolescents aged 12 and above

by
Updated
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement

Read more